📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Atlab Pharma

1.1 - Company Overview

Atlab Pharma Logo

Atlab Pharma

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antibody-targeted anti-cancer drugs and radioimmunotherapy, developing monoclonal antibody-radioisotope conjugates to deliver tumor-specific radiation to cancer cells wherever they have disseminated in the body.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Atlab Pharma

Affinivax Logo

Affinivax

HQ: United States Website
  • Description: Provider of vaccine R&D targeting infectious diseases, using its MAPS (Multiple Antigen Presenting System) platform to enable broader coverage by combining polysaccharides and proteins. Offerings include AFX3772, a 24-valent pneumococcal vaccine candidate in phase II for S. pneumoniae prevention in adults and children, and a 30-plus valent pneumococcal candidate in pre-clinical development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affinivax company profile →
Calypso Biotech Logo

Calypso Biotech

HQ: Switzerland Website
  • Description: Provider of biopharmaceutical research and development focused on therapeutics for autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calypso Biotech company profile →
Stallergenes Greer Logo

Stallergenes Greer

HQ: United Kingdom Website
  • Description: Provider of allergy immunotherapy products and services and molecular diagnostics for respiratory allergies, spanning sublingual and oral treatments for allergic rhinitis, asthma, grass pollen, house dust mite, and peanut allergies. Products include Staloral, Oralair, Actair, Palforzia, SLIT-liquid, and tools to identify specific allergens to guide prescription and composition of immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stallergenes Greer company profile →
Alexion Logo

Alexion

HQ: United States Website
  • Description: Provider of biologic therapies for severe, life-threatening diseases, including hematologic, kidney and neurologic conditions, transplant rejection, cancer and autoimmune disorders; portfolio includes SOLIRIS (PNH, aHUS, NMOSD), ULTOMIRIS (PNH, aHUS), STRENSIQ (HPP) and KANUMA (LAL-D), plus patient support and managed access programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alexion company profile →
Ducentis Biotherapeutics Logo

Ducentis Biotherapeutics

HQ: United Kingdom Website
  • Description: Provider of pre-clinical-stage development of novel therapies for inflammation and autoimmune disease, targeting the CD200/CD200R axis to impart deactivating signals to activated immune cells in both innate and adaptive immunity, with potential therapeutic targets including transplant rejection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ducentis Biotherapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Atlab Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Atlab Pharma

2.2 - Growth funds investing in similar companies to Atlab Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Atlab Pharma

4.2 - Public trading comparable groups for Atlab Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Atlab Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Atlab Pharma

What does Atlab Pharma do?

Atlab Pharma is a provider of antibody-targeted anti-cancer drugs and radioimmunotherapy, developing monoclonal antibody-radioisotope conjugates to deliver tumor-specific radiation to cancer cells wherever they have disseminated in the body.

Who are Atlab Pharma's competitors?

Atlab Pharma's competitors and similar companies include Affinivax, Calypso Biotech, Stallergenes Greer, Alexion, and Ducentis Biotherapeutics.

Where is Atlab Pharma headquartered?

Atlab Pharma is headquartered in France.

How many employees does Atlab Pharma have?

Atlab Pharma has 1,000 employees 🔒.

When was Atlab Pharma founded?

Atlab Pharma was founded in 2010 🔒.

What sector and industry vertical is Atlab Pharma in?

Atlab Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Atlab Pharma

Who are the top strategic acquirers in Atlab Pharma's sector and industry

Top strategic M&A buyers and acquirers in Atlab Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Atlab Pharma?

Top strategic M&A buyers groups and sectors for Atlab Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Atlab Pharma's sector and industry vertical

Which are the top PE firms investing in Atlab Pharma's sector and industry vertical?

Top PE firms investing in Atlab Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Atlab Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Atlab Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Atlab Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Atlab Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Atlab Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Atlab Pharma?

The key public trading comparables and valuation benchmarks for Atlab Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Atlab Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Atlab Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Atlab Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Atlab Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Atlab Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Atlab Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Atlab Pharma